Non Invasive Prenatal Testing Market (By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Non Invasive Prenatal Testing Market, By Gestation Period

7.1.  Non Invasive Prenatal Testing Market, By Gestation Period, 2020-2030

7.1.1.    0-12 Weeks

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    13-24 Weeks

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    25-36 Weeks

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Non Invasive Prenatal Testing Market, By Risk Type

8.1.  Non Invasive Prenatal Testing Market, By Risk Type, 2020-2030

8.1.1.    High & Average Risk

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Low Risk

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Non Invasive Prenatal Testing Market, By Method Type

9.1.  Non Invasive Prenatal Testing Market, By Method Type, 2020-2030

9.1.1.    Ultrasound Detection

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Biochemical Screening Tests

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cell-Free DNA in Maternal Plasma Tests

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Non Invasive Prenatal Testing Market, By Technology Type

10.1.        Non Invasive Prenatal Testing Market, By Technology Type, 2020-2030

10.1.1.  NGS

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Array Technology

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  PCR

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Other Technologies

10.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Non Invasive Prenatal Testing Market, By Product

11.1.        Non Invasive Prenatal Testing Market, By Product, 2020-2030

11.1.1.  Consumables & Reagents

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Instruments

11.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Non Invasive Prenatal Testing Market, By End-use

12.1.        Non Invasive Prenatal Testing Market, By Risk Type, 2020-2030

12.1.1.  Hospitals & Clinics

12.1.1.1.      Market Revenue and Forecast (2016-2030)

12.1.2.  Diagnostic Laboratories

12.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 13.      Global Non Invasive Prenatal Testing  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, By Gestation Period (2016-2030)

13.1.2.  Market Revenue and Forecast, By Risk (2016-2030)

13.1.3.  Market Revenue and Forecast, By Method (2016-2030)

13.1.4.  Market Revenue and Forecast, By Technology (2016-2030)

13.1.5.  Market Revenue and Forecast, By Product (2016-2030)

13.1.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, By Gestation Period (2016-2030)

13.1.7.2.      Market Revenue and Forecast, By Risk (2016-2030)

13.1.7.3.      Market Revenue and Forecast, By Method (2016-2030)

13.1.7.4.      Market Revenue and Forecast, By Technology (2016-2030)

13.1.8.  Market Revenue and Forecast, By Product (2016-2030)

13.1.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.1.9.  Rest of North America

13.1.9.1.      Market Revenue and Forecast, By Gestation Period (2016-2030)

13.1.9.2.      Market Revenue and Forecast, By Risk (2016-2030)

13.1.9.3.      Market Revenue and Forecast, By Method (2016-2030)

13.1.9.4.      Market Revenue and Forecast, By Technology (2016-2030)

13.1.10.               Market Revenue and Forecast, By Product (2016-2030)

13.1.11.               Market Revenue and Forecast, By End-use (2016-2030)

13.1.11.1.    

13.2.        Europe

13.2.1.  Market Revenue and Forecast, By Gestation Period (2016-2030)

13.2.2.  Market Revenue and Forecast, By Risk (2016-2030)

13.2.3.  Market Revenue and Forecast, By Method (2016-2030)

13.2.4.  Market Revenue and Forecast, By Technology (2016-2030)

13.2.5.  Market Revenue and Forecast, By Product (2016-2030)

13.2.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.2.7.   

13.2.8.  UK

13.2.8.1.      Market Revenue and Forecast, By Gestation Period (2016-2030)

13.2.8.2.      Market Revenue and Forecast, By Risk (2016-2030)

13.2.8.3.      Market Revenue and Forecast, By Method (2016-2030)

13.2.9.  Market Revenue and Forecast, By Technology (2016-2030)

13.2.10.               Market Revenue and Forecast, By Product (2016-2030)

13.2.10.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.11.               Germany

13.2.11.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.2.11.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.2.11.3.   Market Revenue and Forecast, By Method (2016-2030)

13.2.12.               Market Revenue and Forecast, By Technology (2016-2030)

13.2.13.               Market Revenue and Forecast, By Product (2016-2030)

13.2.14.               Market Revenue and Forecast, By End-use (2016-2030)

13.2.14.1.    

13.2.15.               France

13.2.15.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.2.15.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.2.15.3.   Market Revenue and Forecast, By Method (2016-2030)

13.2.15.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.2.16.               Market Revenue and Forecast, By Product (2016-2030)

13.2.16.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.17.               Rest of Europe

13.2.17.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.2.17.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.2.17.3.   Market Revenue and Forecast, By Method (2016-2030)

13.2.17.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.2.18.               Market Revenue and Forecast, By Product (2016-2030)

13.2.18.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, By Gestation Period (2016-2030)

13.3.2.  Market Revenue and Forecast, By Risk (2016-2030)

13.3.3.  Market Revenue and Forecast, By Method (2016-2030)

13.3.4.  Market Revenue and Forecast, By Technology (2016-2030)

13.3.5.  Market Revenue and Forecast, By Product (2016-2030)

13.3.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, By Gestation Period (2016-2030)

13.3.7.2.      Market Revenue and Forecast, By Risk (2016-2030)

13.3.7.3.      Market Revenue and Forecast, By Method (2016-2030)

13.3.7.4.      Market Revenue and Forecast, By Technology (2016-2030)

13.3.8.  Market Revenue and Forecast, By Product (2016-2030)

13.3.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.10.               China

13.3.10.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.3.10.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.3.10.3.   Market Revenue and Forecast, By Method (2016-2030)

13.3.10.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.3.11.               Market Revenue and Forecast, By Product (2016-2030)

13.3.11.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.12.               Japan

13.3.12.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.3.12.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.3.12.3.   Market Revenue and Forecast, By Method (2016-2030)

13.3.12.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.3.12.5.   Market Revenue and Forecast, By Product (2016-2030)

13.3.12.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.13.               Rest of APAC

13.3.13.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.3.13.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.3.13.3.   Market Revenue and Forecast, By Method (2016-2030)

13.3.13.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.3.13.5.   Market Revenue and Forecast, By Product (2016-2030)

13.3.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, By Gestation Period (2016-2030)

13.4.2.  Market Revenue and Forecast, By Risk (2016-2030)

13.4.3.  Market Revenue and Forecast, By Method (2016-2030)

13.4.4.  Market Revenue and Forecast, By Technology (2016-2030)

13.4.5.  Market Revenue and Forecast, By Product (2016-2030)

13.4.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, By Gestation Period (2016-2030)

13.4.7.2.      Market Revenue and Forecast, By Risk (2016-2030)

13.4.7.3.      Market Revenue and Forecast, By Method (2016-2030)

13.4.7.4.      Market Revenue and Forecast, By Technology (2016-2030)

13.4.8.  Market Revenue and Forecast, By Product (2016-2030)

13.4.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.10.               North Africa

13.4.10.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.4.10.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.4.10.3.   Market Revenue and Forecast, By Method (2016-2030)

13.4.10.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.4.11.               Market Revenue and Forecast, By Product (2016-2030)

13.4.12.               Market Revenue and Forecast, By End-use (2016-2030)

13.4.13.               South Africa

13.4.13.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.4.13.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.4.13.3.   Market Revenue and Forecast, By Method (2016-2030)

13.4.13.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.4.13.5.   Market Revenue and Forecast, By Product (2016-2030)

13.4.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.14.               Rest of MEA

13.4.14.1.   Market Revenue and Forecast, By Gestation Period (2016-2030)

13.4.14.2.   Market Revenue and Forecast, By Risk (2016-2030)

13.4.14.3.   Market Revenue and Forecast, By Method (2016-2030)

13.4.14.4.   Market Revenue and Forecast, By Technology (2016-2030)

13.4.14.5.   Market Revenue and Forecast, By Product (2016-2030)

13.4.14.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, By Gestation Period (2016-2030)

13.5.2.  Market Revenue and Forecast, By Risk (2016-2030)

13.5.3.  Market Revenue and Forecast, By Method (2016-2030)

13.5.4.  Market Revenue and Forecast, By Technology (2016-2030)

13.5.5.  Market Revenue and Forecast, By Product (2016-2030)

13.5.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, By Gestation Period (2016-2030)

13.5.7.2.      Market Revenue and Forecast, By Risk (2016-2030)

13.5.7.3.      Market Revenue and Forecast, By Method (2016-2030)

13.5.7.4.      Market Revenue and Forecast, By Technology (2016-2030)

13.5.8.  Market Revenue and Forecast, By Product (2016-2030)

13.5.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.5.9.  Rest of LATAM

13.5.9.1.      Market Revenue and Forecast, By Gestation Period (2016-2030)

13.5.9.2.      Market Revenue and Forecast, By Risk (2016-2030)

13.5.9.3.      Market Revenue and Forecast, By Method (2016-2030)

13.5.9.4.      Market Revenue and Forecast, By Technology (2016-2030)

13.5.9.5.      Market Revenue and Forecast, By Product (2016-2030)

13.5.9.6.      Market Revenue and Forecast, By End-use (2016-2030)

Chapter 14.  Company Profiles

14.1.              Genesis Genetics (CooperSurgical, Inc.)

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              Natera, Inc.

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Centogene N.V.

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              Illumina, Inc. (Verinata Health, Inc.)

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              Eurofins LifeCodexx GmbH

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              MedGenome Labs Ltd.

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              Progenity, Inc.

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           Qiagen

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

14.11.           Laboratory Corp. of America Holdings

14.11.1.               Company Overview

14.11.2.               Product Offerings

14.11.3.               Financial Performance

14.11.4.               Recent Initiatives

14.12.           Quest Diagnostics, Inc.

14.12.1.               Company Overview

14.12.2.               Product Offerings

14.12.3.               Financial Performance

14.12.4.               Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

Glossary of Terms